Abbott Laboratories Aktie News

Abbott (NYSE: ABT) recently reported its Q1 results, with revenues above and earnings exceeding our expectations. The company reported revenue of $10 billion and earnings of $0.98 on a per-share and adjusted basis, compared to our estimates of $9.9 billion and $0.95, respectively.

Focusing on consistent dividend growth can lead to higher returns in lower-risk areas. The portfolio emphasizes companies with wide-moat business models, strong financials, and a commitment to shareholder returns. Blending higher-yielding dividend stocks with those offering growth potential creates a balanced approach suitable for most investors.

Shares of Abbott Laboratories (ABT) fell in intraday trading Wednesday, with second-quarter guidance seeming to outweigh first-quarter results that beat analyst estimates.

Abbott Laboratories (NYSE:ABT ) Q1 2024 Results Conference Call April 17, 2024 9:00 AM ET Company Participants Mike Comilla - Vice President, Investor Relations Robert Ford - Chairman and Chief Executive Officer Phil Boudreau - Senior Vice President, Finance and Chief Financial Officer Bob Funck - Executive Vice President, Finance Conference Call Participants Robbie Marcus - JPMorgan Larry Bieg...

Abbott Laboratories' NYSE: ABT share price was corrected at the end of CQ1 2024 on growth, profitability and capital returns concerns. The FQ1 results, however, belie the fear and have the market set up for a rebound that could last for several quarters.

Abbott Laboratories on April 17 reported a 2.2% rise of $10 billion in its 2024 first-quarter sales which includes the impact of the anticipated decline in COVID-19 testing-related sales as compared to the previous year. Organic sales grew for the underlying base business of 10.8%, which represents the fifth consecutive quarter of double-digit growth.

Healthcare-products firm Abbott Laboratories' first-quarter earnings beat expectations, but second-quarter guidance was light.

Abbott stock see-sawed early Wednesday after the giant health care company reported adjusted income of 98 cents a share on $10 billion in first-quarter sales.